MENU
+Compare
CZMWY
Stock ticker: OTC
AS OF
Aug 29 closing price
Price
$50.42
Change
-$0.25 (-0.49%)
Capitalization
4.43B

CZMWY Carl Zeiss Meditec AG Forecast, Technical & Fundamental Analysis

Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery... Show more

CZMWY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CZMWY with price predictions
Aug 29, 2025

CZMWY sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for CZMWY moved below the 200-day moving average on August 19, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 27, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CZMWY as a result. In of 73 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CZMWY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CZMWY entered a downward trend on August 20, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CZMWY's RSI Indicator exited the oversold zone, of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 59 cases where CZMWY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CZMWY just turned positive on August 19, 2025. Looking at past instances where CZMWY's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CZMWY advanced for three days, in of 233 cases, the price rose further within the following month. The odds of a continued upward trend are .

CZMWY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.825) is normal, around the industry mean (10.937). P/E Ratio (25.319) is within average values for comparable stocks, (58.298). Projected Growth (PEG Ratio) (1.179) is also within normal values, averaging (1.854). Dividend Yield (0.013) settles around the average of (0.016) among similar stocks. P/S Ratio (1.739) is also within normal values, averaging (38.374).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CZMWY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CZMWY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
CZMWY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CZMWY is expected to report earnings to rise 84.40% to 80 cents per share on December 11

Carl Zeiss Meditec AG CZMWY Stock Earnings Reports
Q3'25
Est.
$0.80
Q2'25
Missed
by $0.16
Q1'25
Beat
by $0.15
Q3'24
Beat
by $0.12
Q2'24
Beat
by $0.01
The last earnings report on August 07 showed earnings per share of 43 cents, missing the estimate of 59 cents. With 1.38K shares outstanding, the current market capitalization sits at 4.43B.
A.I.Advisor
published Dividends

CZMWY paid dividends on April 15, 2025

Carl Zeiss Meditec AG CZMWY Stock Dividends
А dividend of $0.65 per share was paid with a record date of April 15, 2025, and an ex-dividend date of March 28, 2025. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
Goschwitzer Strasse 51-52
Phone
+49 3641220115
Employees
4823
Web
https://www.zeiss.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NWHHX16.27-0.02
-0.12%
Nationwide Bailard Cogntv Val Instl Svc
CMLAX60.93-0.12
-0.20%
American Funds American Mutual 529A
PHEIX13.30-0.06
-0.45%
T. Rowe Price Hedged Equity I
DSFRX39.56-0.21
-0.53%
Domini Impact Equity Y
MIGWX28.61-0.32
-1.11%
Marsico Growth Institutional

CZMWY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CZMWY has been loosely correlated with SMMNY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CZMWY jumps, then SMMNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CZMWY
1D Price
Change %
CZMWY100%
-0.49%
SMMNY - CZMWY
44%
Loosely correlated
-0.14%
SONVY - CZMWY
38%
Loosely correlated
+1.39%
SAUHY - CZMWY
37%
Loosely correlated
-1.61%
ALGN - CZMWY
37%
Loosely correlated
+0.59%
ALC - CZMWY
36%
Loosely correlated
+0.47%
More

Groups containing CZMWY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CZMWY
1D Price
Change %
CZMWY100%
-0.49%
Pharmaceuticals
category (388 stocks)
28%
Poorly correlated
+0.23%
Pharmaceuticals: Other
category (104 stocks)
24%
Poorly correlated
+0.57%